Open Government Portal
Found 10 records similar to COVID-19: Recommendations for those vaccinated with vaccines not authorized by Health Canada for those staying in Canada to live, work or study
Immunizing all Canadians with COVID-19 vaccine in a timely way will be a major challenge. In support of this massive undertaking, the Public Health Agency of Canada (PHAC) has developed planning guidance for the administration of COVID-19 vaccine.
The purpose of this document is to assist in planning immunization clinics for COVID-19 vaccines during the COVID-19 pandemic.
Pregnancy increases the risk of severe illness from COVID-19. The National Advisory Committee on Immunization (NACI) recommends you get a complete series with an mRNA COVID-19 vaccine if you're pregnant or breastfeeding. Getting the COVID-19 vaccine can prevent serious illness, hospitalization and complications.
COVID-19 vaccines are safe and effective. Free vaccines will be available to everyone who lives in Canada over the course of 2021.
Until extensive immunization is achieved, public health measures will continue to be essential to minimize the spread of COVID-19 in Canada and save lives.
This page is a summary of National Advisory Committee on Immunization (NACI) statement: Recommendations on the use of COVID-19 vaccines.
The objective of the Interim National Vaccine Storage, Handling and Transportation Guidelines for Ultra-Low Temperature and Frozen Temperature COVID-19 Vaccines – 2021 is to supplement and update the guidance for storage, handling and transportation of ultra-low temperature and frozen temperature COVID-19 vaccines for immunization providers in Canada.
This dataset provides the cumulative number of COVID-19 vaccine doses administered in Canada by jurisdiction, vaccine product, and report date. Variables include:
Jurisdiction ID number
Cumulative number of COVID-19 vaccine doses administered
Cumulative number of Pfizer-BioNTech COVID-19 vaccine doses administered
Cumulative number of Moderna COVID-19 vaccine doses administered
Cumulative number of COVID-19 vaccine (unknown product) doses administered
As of date
For variable definitions, see the data dictionary. For details regarding data sources and limitations, see the technical notes section of the Canadian COVID-19 vaccination coverage report (https://health-infobase.canada.ca/covid-19/vaccination-coverage/technical-notes.html).
Since COVID-19 vaccines were first authorized in Canada in December 2020, the National Advisory Committee on Immunization (NACI) has been providing evidence-informed guidance on the recommended interval between vaccine doses.
COVID-19 is a new disease not previously identified in humans. Currently there is no vaccine or therapeutic product for COVID-19 that is authorized to treat or prevent the disease. The outbreak of COVID-19 has resulted in a global review of therapies that could be used to treat or prevent the infection. In an effort to facilitate earlier access to a vaccine, or therapeutic product for COVID-19, the Department will expedite the review of any COVID-19 related health product submissions and applications.
When people still show symptoms of COVID-19 for weeks or months after their initial recovery, it’s called post COVID-19 condition. It’s also known as long COVID. Post COVID-19 condition may occur in some people after infection.